Beata Halassy, an expert infectious disease researcher, treated her own stage 3 breast cancer by injecting the tumour with ...

Candel Therapeutics aims to revolutionize cancer treatment with oncolytic virus therapy, awaiting crucial trial results in Q4 ...

Virologist Beata Halassy, ​​facing a recurrent tumor, develops and tests on herself an innovative therapy: here is her story.

An infectious diseases expert has raised eyebrows after she successfully treated her own breast cancer by injecting her ...

Virologist treats breast cancer with oncolytic virotherapy, shrinking the tumor and boosting immune response. An ...

and we look forward to continuing our work together as we develop this promising therapy further.” Reference: Ning W, Qian X, ...

Researchers from Queen Mary University of London, the Chinese Academy of Sciences and Capital Medical University in Beijing ...

Clinical-stage immuno-oncology company Imugene is celebrating more than two years’ “complete response” for one of its bile ...

Replimune Group (REPL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Robert ...

MB-108 shows activity and is well tolerated in recurrent glioblastoma, with preclinical data supporting its combination with ...

Our novel therapeutic strategy, combining our MB-108 oncolytic virus with MB-101 CAR-T cell therapy, could be the first-ever ...

Imugene stocks well placed to grow with clinical progress on azer-cel CAR T-cell therapy and strong cash position, say analysts ...